Anavex Life Sciences Corp (AVXL)

[Investor2014]

“This is an important development as the patients who have completed the main study, ANAVEX2-73-AD-004, are consistently expressing the wish to gain ongoing access to this investigational therapy,” says A/Professor Stephen Macfarlane, FRANZCP, Head of Clinical Services at the Dementia Centre, HammondCare and Principal Investigator for both studies.

Maybe A2-73 works a little better than 10 cups of coffee?